Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$274,800
in 1 filing

Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Charney Laurence N −$275K Director sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-07-06 KENNEDY WILLIAM JAMES Director Grant or award +12,459 78,949
2016-07-06 Charney Laurence N Director Grant or award +12,459 95,949
2016-07-05 Power Sean A CFO, Secretary and Treasurer Sale −50,426 $5.99 $302K 416,256
2016-04-18 Power Sean A CFO, Secretary and Treasurer Sale −10,000 $10.12 $101K 466,682
2016-01-05 Power Sean A CFO, Secretary and Treasurer Sale −22,790 $11.21 $255K 476,682
2015-12-31 WEISS MICHAEL S Grant or award +672,343 9,398,976
2015-12-31 Power Sean A CFO, Secretary and Treasurer Grant or award +50,000 499,472
2015-12-31 WEISS MICHAEL S Grant or award +6,723,443 9,398,976
2015-07-08 KENNEDY WILLIAM JAMES Director Sale −17,000 $17.08 $290K 66,490
2015-07-01 Power Sean A CFO, Secretary and Treasurer Sale −50,054 $16.46 $824K 449,472
2015-06-04 Echelard Yann Director Grant or award +4,667 74,609
2015-06-04 KENNEDY WILLIAM JAMES Director Grant or award +4,667 83,490
2015-06-04 Charney Laurence N Director Grant or award +4,667 83,490
2015-06-04 SCHOENEBAUM MARK Director Grant or award +4,667 83,490
2015-06-04 WEISS MICHAEL S Grant or award +337,257 8,726,633
2015-06-04 Hoberman Kenneth Director Grant or award +4,667 74,446
2015-05-07 LFB Biotechnologies S.A.S.U. 10% owner Option exercise +2,500,000 $0.00 $3K 7,614,855
2015-05-07 LFB Biotechnologies S.A.S.U. 10% owner Option exercise · Warrants to Purchase Common Stock −2,500,000 0
2015-04-02 Power Sean A CFO, Secretary and Treasurer Sale −11,000 $15.51 $171K 499,526
2015-04-01 Power Sean A CFO, Secretary and Treasurer Sale −12,800 $15.50 $198K 510,526

Page 8 of 13 · 253 trades